Literature DB >> 6092335

Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates.

T Sasaki, T Kikuchi, N Yumoto, N Yoshimura, T Murachi.   

Abstract

Homogeneous porcine calpain (Ca2+-dependent cysteine proteinase) was found to hydrolyze a variety of peptides and synthetic substrates. Leu-Trp-Met-Arg-Phe-Ala, eledoisin-related peptide, alpha-neoendorphin, angiotensin I, luteinizing hormone-releasing hormone, neurotensin, dynorphin, glucagon, and oxidized insulin B chain were cleaved with a general preference for a Tyr, Met, or Arg residue in the P1 position preceded by a Leu or Val residue in the P2 position. No great difference in specificity was found between low-Ca2+-requiring calpain I and high-Ca2+-requiring calpain II. 4-Methylcoumaryl-7-amide (MCA) derivatives having a Leu(or Val)-Met(or Tyr)-MCA or a Leu-Lys-MCA sequence were also cleaved by either calpain I or calpain II with preference for Leu over Val by a factor of 9 to 16. Calpains I and II showed similar but not identical kinetic behavior for individual substrates. The Km and kcat values ranged from 0.23 to 7.08 mM and 0.062 to 0.805 s-1 for the calpains, while kcat/Km values for the calpains were only 1/433 to 1/5 of those for papain with a given substrate. With succinyl-Leu-Met(or Tyr)-MCA, calpains I and II were half-maximally activated at 12 and 260 microM Ca2+, respectively, and competitively inhibited by leupeptin (Ki = 0.32 microM for I and 0.43 microM for II) or antipain (Ki = 1.41 microM for I and 1.45 microM for II). Thus, this is the first report describing the specificity and kinetics of calpains I and II.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092335

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective.

Authors:  K K Wang; R Nath; A Posner; K J Raser; M Buroker-Kilgore; I Hajimohammadreza; W Probert A; F W Marcoux; Q Ye; E Takano; M Hatanaka; M Maki; H Caner; J L Collins; A Fergus; K S Lee; E A Lunney; S J Hays; P Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  The inactivation of the cysteinyl exopeptidases cathepsin H and C by affinity-labelling reagents.

Authors:  H Angliker; P Wikstrom; H Kirschke; E Shaw
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

3.  Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system.

Authors:  S L Meyer; D Bozyczko-Coyne; S K Mallya; C M Spais; R Bihovsky; J K Kaywooya; D M Lang; R W Scott; R Siman
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

Review 4.  Calmodulin-binding proteins as calpain substrates.

Authors:  K K Wang; A Villalobo; B D Roufogalis
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

5.  Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration.

Authors:  Yubin Wang; Victor Briz; Athar Chishti; Xiaoning Bi; Michel Baudry
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

6.  Mechanisms of antagonistic action of internal Ca2+ on serotonin-induced potentiation of Ca2+ currents in Helix neurones.

Authors:  P G Kostyuk; E A Lukyanetz
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

7.  The role of cysteine proteases in hypoxia-induced rat renal proximal tubular injury.

Authors:  C L Edelstein; E D Wieder; M M Yaqoob; P E Gengaro; T J Burke; R A Nemenoff; R W Schrier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Limitations of SLLVY-AMC in calpain and proteasome measurements.

Authors:  Christopher J Giguere; Rick G Schnellmann
Journal:  Biochem Biophys Res Commun       Date:  2008-05-05       Impact factor: 3.575

9.  Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases.

Authors:  G Salvesen; C Parkes; M Abrahamson; A Grubb; A J Barrett
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

10.  Methylglyoxal alters the function and stability of critical components of the protein quality control.

Authors:  Carla Figueira Bento; Filipa Marques; Rosa Fernandes; Paulo Pereira
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.